首页--医药、卫生论文--内科学论文--内分泌腺疾病及代谢病论文--代谢病论文

抗氧化剂对甲状腺功能异常引起的代谢综合征的保护作用

DEDICATION第5-6页
ACKNOWLEDGEMENT第6-7页
LIST OF FIGURES第7-8页
LIST OF TABLES第8-9页
LIST OF ABBREVIATIONS AND ACRONYMS第9-11页
ABSTRACT第11-13页
摘要第14-21页
CHAPTER ONE INTRODUCTION AND LITERATURE REVIEW第21-52页
    1.1. Introduction第21-25页
        1.1.1. Problem statement and justification of the study第23-24页
        1.1.2. Objectives of the study第24-25页
    1.2. Literature Review第25-38页
        1.2.1. Metabolic syndrome: definition, controversies, prevalence and clinical significance第25-26页
        1.2.2. Pathophysiology of metabolic syndrome第26-28页
        1.2.3. Components of metabolic syndrome第28-29页
        1.2.4. Risk factors associated with metabolic syndrome第29-31页
        1.2.5. Metabolic syndrome and occupation第31-32页
        1.2.6. Metabolic syndrome and oxidative stress第32-33页
        1.2.7. Metabolic syndrome and thyroid dysfunction第33-34页
        1.2.8. Thyroid hormones, metabolism and oxidative stress第34-35页
        1.2.9. Oxidative stress effects on the heart and antioxidant protection第35-36页
        1.2.10. Oxidative stress effects on the kidney and antioxidant protection第36-37页
        1.2.11. Oxidative stress effects on the lungs and antioxidant protection第37-38页
    1.3. Summary of literature review and conceptual frame work of the study第38-40页
    1.4. References第40-52页
CHAPTER TWO PREVALENCE OF METABOLIC SYNDROME AND ITS COMPONENTS AMONG WORKERS第52-66页
    2.1. Introduction第52-53页
    2.2. Materials and Methods第53-54页
        2.2.1. Study participants and research design第53页
        2.2.2. Data collection: physical assessment, blood sample collection and preparation第53-54页
        2.2.3. Definition of metabolic syndrome第54页
    2.3. Statistical analysis第54页
    2.4. Results第54-60页
        2.4.1. Anthropometric and metabolic parameters of the study population第54-55页
        2.4.2. Sex-specific prevalence of the number of metabolic syndrome components by age groups第55-56页
        2.4.3. Prevalence of metabolic syndrome and its components by sex and age groups第56-57页
        2.4.4. Association of metabolic syndrome and its components with occupation第57-60页
        2.4.5. Prevalence of metabolic syndrome and its components in academic workers by professional positions第60页
    2.5. Discussion第60-62页
    2.6. Conclusion第62-63页
    2.7. References第63-66页
CHAPTER THREE RELATIONSHIP BETWEEN METABOLIC SYNDROME COMPONENTS AND SUBCLINICAL HYPOTHYROIDISM第66-83页
    3.1. Introduction第66-67页
    3.2. Materials and Methods第67-68页
        3.2.1. Participants and research design第67页
        3.2.2. Evaluation of thyroid function parameters第67-68页
    3.3. Statistical analysis第68页
    3.4. Results第68-74页
        3.4.1. Anthropometric and metabolic parameters of study participants第68-69页
        3.4.2. Thyroid function and metabolic syndrome components第69-70页
        3.4.3. Metabolic parameters in euthyroidism and subclinical hypothyroidism第70-71页
        3.4.4. Association between thyroid stimulating hormone and metabolic parameters第71-73页
        3.4.5. Occupation and subclinical hypothyroidism第73-74页
    3.5. Discussion第74-78页
    3.6. Conclusion第78-79页
    3.7. References第79-83页
CHAPTER FOUR RELATIONSHIP BETWEEN SUBCLINICAL HYPOTHYROIDISM AND OXIDATIVE STRESS第83-98页
    4.1. Introduction第83-84页
    4.2. Materials and Methods第84-85页
        4.2.1. Participants and research design第84页
        4.2.2. Evaluation of oxidative stress markers第84-85页
    4.3. Statistical analysis第85页
    4.4. Results第85-92页
        4.4.1. Lipid parameters and thyroid function第85-88页
        4.4.2. Oxidative stress markers and thyroid function第88-90页
        4.4.3. Oxidative stress markers and lipid parameters第90-92页
    4.5. Discussion第92-94页
    4.6. Conclusion第94-95页
    4.7. References第95-98页
CHAPTER FIVE CARDIOPROTECTIVE EFFECTS OF LIPOIC ACID, RESVERATROL AND QUERCETIN第98-120页
    5.1. Introduction第98-100页
    5.2. Materials and methods第100-103页
        5.2.1. Animals and experimental design第100页
        5.2.2. Measurement of blood pressure and heart pulse rate第100-101页
        5.2.3. Sample collection: Blood and tissue preparations第101页
        5.2.4. Measurement of circulating thyroid stimulating hormone and thyroid hormones ...81第101页
        5.2.5. Measurement of tissue oxidative stress markers第101-102页
        5.2.6. Reverse transcription and real-time polymerase chain reaction第102-103页
    5.3. Statistical analysis第103页
    5.4. Results第103-110页
        5.4.1. Changes in body weight, blood pressure, heart pulse rate and tissue weight/mice weight ratio第103-105页
        5.4.2. Changes in thyroid stimulating hormone and thyroid hormone levels at 26 weeks.85第105页
        5.4.3. Changes in oxidative stress markers in the heart during the feeding period第105-107页
        5.4.4. Changes in activities of enzymes involved in blood pressure regulation, endothelial function and cellular Ca2+transport in the heart第107-108页
        5.4.5. Relative changes in left ventricular gene expression at 26 week of feeding第108-110页
    5.5. Discussion第110-115页
    5.6. Conclusion第115-116页
    5.7. References第116-120页
CHAPTER SIX PROTECTIVE EFFECTS OF LIPOIC ACID, RESVERATROL AND QUERCETIN ON THE KIDNEY AND LUNGS第120-138页
    6.1. Introduction第120-122页
    6.2. Materials and methods第122页
    6.3. Statistical analysis第122页
    6.4. Results第122-130页
        6.4.1. Changes in tissue weight/mice weight ratio of the kidney and lungs第122-123页
        6.4.2. Changes in oxidative stress markers in the kidney during the feeding period第123-124页
        6.4.3. Changes in oxidative stress markers in the lungs during the feeding period第124-125页
        6.4.4. Effect of diet on ACE, NOS, Na+/K+-ATPase and Ca (2+)-ATPase activity in the kidney第125-126页
        6.4.5. Relative changes in renal expression of TRα1, DIO1, Akt, GSK3β, NrF2 and its target genes at 26 week of feeding第126-127页
        6.4.6. Relative expression of genes involved in rennin angiotensin system, endothelial function, Ca2+ transport, fibrosis and apoptosis in the kidney第127-129页
        6.4.7. Relative expression of genes involved in rennin angiotensin system, ATP1B1 and NF-κB in the lungs第129-130页
    6.5. Discussion第130-133页
    6.6. Conclusion第133-134页
    6.7. References第134-138页
GENERAL CONCLUSIONS AND RECOMMENDATIONS第138-141页
    CONCLUSIONS第138-140页
    RECOMMENDATIONS第140-141页
KEY INNOVATIONS第141-142页
PUBLISHED ARTICLES第142-143页
APPENDICES第143-145页

论文共145页,点击 下载论文
上一篇:HSYA改善Aβ1-42诱导AD小鼠认知功能及其机制研究
下一篇:梭梭萌发定居过程中的致死因素与存活策略研究